Surgical approach to pleuropulmonary solitary fibrous tumour in the anterior mediastinum: Case series at a third-level centre | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Case Report Surgical approach to pleuropulmonary solitary fibrous tumour in the anterior mediastinum: Case series at a third-level centre Amelia Fernández-Avendaño, Mónica Martínez-Ferman, Pablo Gomes-da Silva de Rosenzweig, and 5 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-8000935/v1 This work is licensed under a CC BY 4.0 License Status: Under Review Version 1 posted 15 You are reading this latest preprint version Abstract Solitary fibrous tumour (SFT) is an uncommon neoplasm, and its occurrence in the anterior mediastinum is particularly rare, as other differential diagnoses would initially be considered. Clinically, SFTs are typically asymptomatic and are often discovered incidentally through imaging studies. Definitive treatment is achieved through complete surgical resection with negative margins, followed by subsequent histopathological analysis. We present three cases of anterior mediastinal SFT managed at our institution in 2024, treated via both open surgery and a minimally invasive approach using robotic-assisted thoracic surgery. Additionally, we discussed the clinical considerations and criteria guiding the choice between open and robotic surgical approaches. Pleuropulmonary neoplasia anterior mediastinum robot-assisted surgery solitary fibrous tumour Figures Figure 1 Figure 2 Figure 3 Figure 4 Introduction Solitary fibrous tumour (SFT) accounts for approximately 3.7–5% of soft tissue sarcomas and mesenchymal neoplasms. Between 12% and 32% of cases exhibit malignant behaviour, typically affecting individuals between 50 and 70 years of age. Its pathogenesis is associated with a chromosomal inversion at 12q13, resulting in the fusion of the NAB2 and STAT6 genes ( 1 – 2 ). These tumours typically arise from serous membranes, with approximately 30% occurring within the thoracic cavity ( 3 ). Of thoracic cases, most originate from the visceral pleura and are often attached to the lung by a pedicle. The clinical presentation is variable and often nonspecific, presenting with symptoms such as cough, dyspnea, and chest pain ( 4 – 5 ). The standard treatment for SFT is complete surgical resection with negative margins. Historically, this has been achieved through thoracotomy; however, given the advantages of minimally invasive approaches, such as reduced intraoperative blood loss and shorter length of hospital stay, both video-assisted thoracic surgery (VATS) and robotic-assisted thoracic surgery (RATS) have emerged as feasible alternatives for tumour resection ( 6 – 8 ). The objective of this case series is to present our experience in managing SFT using both conventional open surgery and a minimally invasive robotic-assisted approach. Case series Case 1 (Fig. 1 ) A 67-year-old female presented with a one-month history of progressive dyspnea, which advanced to orthopnea, rendering her unable to tolerate the supine position. A chest X-ray revealed a mass in the anterior mediastinum. A computed tomography (CT) guided biopsy confirmed the diagnosis of a SFT, and subsequent magnetic resonance imaging (MRI) demonstrated a mass measuring 15 × 15 × 10 cm. Given the tumour’s size, a median sternotomy was performed. The mass was carefully dissected using harmonic energy, preserving the thymic margins. En bloc resection was achieved, including the pedicle arising from the right pulmonary apex. A 32 French pleural drain was placed. Intraoperative bleeding (IOB) was 200 mL, and the operative time was 1.5 hours. In the immediate postoperative period, the patient experienced hemodynamic instability requiring vasopressor support and transfusion of blood products. She was managed in the intensive care unit (ICU) with advanced airway support for two days, followed by an uneventful recovery. The pleural drain was removed at 48 hours, and the patient was discharged on postoperative day four. Histopathological analysis confirmed a malignant grade 2 SFT. Immunohistochemistry was positive for CD34, STAT6, and BCL2 (Fig. 2 ). Case 2. (Fig. 3) A 54-year-old female with no significant medical history was admitted to the emergency department with a diagnosis of influenza-related pneumonia. A CT scan incidentally revealed a mass in the left anterior mediastinum. An ultrasound-guided biopsy confirmed the diagnosis of a SFT. The patient was scheduled for resection via RATS, utilising four robotic arms. Under general anaesthesia, she was positioned in the right lateral decubitus position. A single 8 mm port was placed in the 7th intercostal space (ICS) for CO₂ insufflation. Under direct visualisation, additional ports were placed at the 7th and 8th ICS along the posterior axillary line, and a 12 mm accessory port was inserted in the 9th ICS along the anterior axillary line. The tumour was identified with firm adhesions to the visceral pleura of the left upper lobe. A wedge resection of the anterior segment was performed using a 60 mm stapler. A 24Fr drain was placed posteriorly, with adequate lung expansion confirmed. IOB was 150 mL, and the procedure lasted 1.5 hours. The patient was successfully extubated in the operating room and experienced an uneventful recovery. The pleural drain was removed on postoperative day two, and she was discharged the same day. Histopathological examination confirmed a benign SFT measuring 9 × 6 × 5 cm and weighing 156 grams, with an R0 resection. The tumour exhibited a fibrous stroma and positive immunohistochemical staining for CD34, Bcl-2, and CD99. Case 3 ( Fig. 3 ). A 71-year-old female with a history of breast cancer and prior mediastinal tumour resection, with histopathology confirming a SFT, presented after a follow-up CT scan revealed a new mediastinal mass, suggestive of SFT recurrence. The patient was scheduled for RATS resection through 4 ports. Three 8 mm robotic ports and one 12 mm accessory port were utilised. Intraoperatively, multiple loose adhesions were encountered. The tumour was located over the ascending aorta, with displacement of the left brachiocephalic venous trunk. Tumour resection was performed using bipolar energy, achieving complete excision. A 24 Fr drain was placed with full lung re-expansion. IOB was 50 mL, and the operative time was 3 hours. The patient was successfully extubated in the operating room and had a favourable postoperative course. The pleural drain was removed on postoperative day four, and she was discharged the same day. Histopathological analysis confirmed a malignant SFT measuring 6.3 × 4.4 × 3.5 cm and weighing 46 grams. R0 resection was achieved. The tumour exhibited positive staining for CD34 and BCL2. Discussion Pleuropulmonary SFTs are rare, with an estimated incidence of 2.8 cases per 100,000 people annually. In Mexico, 26 cases were reported between 2007 and 2017, with a mean age of 52 years and a higher prevalence in females, as described by Ríos-Pascual et al. ( 9 ). The diagnosis is most often incidental, with symptoms typically appearing once the tumour reaches sufficient size to compress adjacent structures. In our series, as well as in the literature, CT scanning is the preferred diagnostic modality for benign tumours, which usually demonstrate a hyperdense, encapsulated mass with a pedunculated growth often attached to the left basal region, arising from the visceral pleura. In contrast, malignant tumours tend to show more invasive growth with organ infiltration, hemorrhagic necrosis, and a higher risk of recurrence ( 10 – 11 ). For diagnostic confirmation, biopsy may be performed, with immunohistochemical positivity for markers such as CD34, CD99, and Bcl-2 ( 9 ). Although most SFTs are benign ( 12 ), when malignant, they may be negative for CD34, which can be explained by tumour dedifferentiation, leading to changes in the expression of surface proteins. As exemplified by our cases, the location of the intrathoracic SFT should guide consideration of the differential diagnosis. For anterior mediastinal tumours, a practical mnemonic is the “4Ts”: thymoma, teratoma, thyroid pathology, and “terrible” lymphoma ( 13 ). Attention to paraneoplastic manifestations may also aid diagnostic certainty. Doege-Potter syndrome, characterised by hypoglycemia due to ectopic insulin-like growth factor production, is described in up to 22% of SFT cases. Pierre-Marie-Bamberg syndrome, although rarer and reported in fewer than 5% of cases, is another recognised paraneoplastic presentation with digital clubbing and hypertrophic osteoarthropathy ( 12 ). The treatment for SFT is surgical resection, which, depending on the extent of the tumour, may require the removal of adherent or invaded tissues. However, Wang et al. reported no significant differences in disease-free survival at five years when comparing organ-sparing versus en bloc resections. This finding, though, should be interpreted with caution, as it may be influenced by the small sample size of the study ( 14 ). Conventionally, resection has been carried out through open surgery, particularly when larger than 5 cm. However, the recent development of minimally invasive thoracic surgery has offered an alternative for the treatment of SFT ( 15 – 16 ). Video-assisted thoracoscopic surgery (VATS) has demonstrated favourable outcomes, as shown in studies by Magdeleinat et al. and Zhou et al. ( 16 – 17 ). Similarly, RATS has emerged as a safe and effective option for SFT resection, as exemplified by our series of patients. Nevertheless, it´s important to note that most published reports remain limited to case series, and no studies have directly compared outcomes between RATS and VATS or RATS and open surgery, despite the early, promising results of robotic resections. While minimally invasive resections offer benefits such as reduced postoperative pain and faster recovery, careful incision planning is essential to ensure an adequate working space and to allow safe tumour extraction while minimising the risk of tumour seeding ( 18 ). Moreover, conversion to open thoracotomy should always be considered when complete resection with clear margins cannot be achieved ( 19 ). In general, SFTs have a good prognosis, with reported overall survival rates of 89–100% at 5 years ( 16 , 20 ). However, this favourable outcome largely applies to benign SFTs. Malignant tumours carry a higher risk of recurrence, with a reported 5-year disease-free status of around 58% and an overall survival of approximately 67% ( 21 ). Although our series is not representative of the typical distribution of benign and malignant SFTs (with a predominance of malignant cases), the cornerstone of treatment remains complete surgical resection. Adjuvant radiotherapy and/or chemotherapy may help reduce recurrence rates in this set of patients; however, their benefit has only been demonstrated in a small number of studies, and overall efficacy remains uncertain ( 5 , 21 ). The limitations of our study include its retrospective nature and the small number of patients in our series. However, a clear need remains for prospective, comparative studies evaluating the outcomes of minimally invasive resections for SFT compared to conventional open approaches. Conclusion The diagnosis of SFT is often incidental, and complete surgical resection is the treatment of choice. Minimally invasive surgery, such as RATS resection, appears to be effective for tumours smaller than 10 cm, with a good postoperative recovery and reduced frequency of complications. Despite its good prognosis, postoperative surveillance is crucial due to the possibility of recurrence in the first two years. A multidisciplinary approach is essential to ensure proper management and optimise outcomes. Abbreviations solitary fibrous tumour (SFT) video-assisted thoracic surgery (VATS) robotic-assisted thoracic surgery (RATS) computed tomography (CT) magnetic resonance imaging (MRI) intensive care unit (ICU) intercostal space (ICS) intraoperative bleeding (IOB) Declarations Data availability Not applicable. Acknowledgements None Funding None provided Ethics approval Patients provided informed consent for publication. Competing interests None declared Author Contribution [AMF, MMF, PGD, DAV, LFA, XLV, LGS ,FVB] performed the literature review and contributed to manuscript drafting. [ LGS ,FVB] supervised the project and critically revised the final version. All authors reviewed and approved the manuscript. References Franzen D, Diebold M, Soltermann A et al. Determinants of outcome of solitary fibrous tumors of the pleura: an observational cohort study. BMC Pulm Med. 2014;14:138. Published 2014 Aug 12. 10.1186/1471-2466-14-138 Schweizer L, Koelsche C, Sahm F, et al. Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein. Acta Neuropathol. 2013;125(5):651–8. 10.1007/s00401-013-1117-6 . Martin-Broto J, Mondaza-Hernandez JL, Moura DS, Hindi N. A Comprehensive Review on Solitary Fibrous Tumor: New Insights for New Horizons. Cancers (Basel). 2021;13(12):2913. 10.3390/cancers13122913 . Published 2021 Jun 10. Khouzam MS, Khouzam N. Malignant solitary fibrous tumor of the pleura. J Cardiothorac Surg. 2022;17(1):92. Published 2022 May 3. 10.1186/s13019-022-01842-6 Gao X, Zhang J, Qian Z, Liu L. Malignant solitary fibrous tumor of the pleura: A narrative review of clinical characteristics, diagnosis and therapeutic options. Respir Med Res. 2022;86:100961. 10.1016/j.resmer.2022.100961 . Gonzalez-Rivas D, Gomes-da Silva de Rosenzweig P, Arana Bolaños LF, et al. Complex uniportal robotic-assisted sleeve resections under spontaneous ventilation and with double lumen intubation: a case series and a narrative review of the literature. Transl Lung Cancer Res. 2025;14(8):3170–82. 10.21037/tlcr-2025-498 . van Reesema LLS, Hutchcraft ML, Freidberg NA, et al. Robot-assisted laparoscopic removal of an extraperitoneal pelvic solitary fibrous tumor. Gynecol Oncol Rep. 2023;47:101198. 10.1016/j.gore.2023.101198 . Published 2023 May 16. Khouzam MS, Khouzam N. Malignant solitary fibrous tumor of the pleura. J Cardiothorac Surg. 2022;17(1):92. Published 2022 May 3. 10.1186/s13019-022-01842-6 Ríos-Pascual S, Vázquez-Minero JC, Garza-Jiménez GO, López-Luna JJ, Islem-Gamboa T. Tumor fibroso solitario de la pleura: Factores asociados a comportamiento maligno y recidiva. Experiencia institucional. Neumol. cir. torax. 2019 March; 78(1): 25–31. Chu X, Zhang L, Xue Z, et al. Solitary fibrous tumor of the pleura: An analysis of forty patients. J Thorac Dis. 2012;4(2):146–54. 10.3978/j.issn.2072-1439.2012.01.05 . Cardinale L. CT Imaging of Solitary fibrous tumour of the pleura (SFTP): Typical Patterns and pitfalls. J Thorac Dis. 2012;4(2):112–3. 10.3978/j.issn.2072-1439.2011.09.01 . Alghamdi ZM, Othman SA, Al-Yousef MJ, AlFadel BZ. Intrapulmonary location of benign solitary fibrous tumor. Ann Thorac Med. 2020;15(2):98–101. 10.4103/atm.ATM_14_20 . Girard N, Ruffini E, Marx A, Faivre-Finn C, Peters S, ESMO Guidelines Committee. Thymic epithelial tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(Suppl 5):v40–55. 10.1093/annonc/mdv277 . Wang Y, Wei R, Ji T, Chen Z, Guo W. Surgical treatment of primary solitary fibrous tumors involving the pelvic ring. PLoS ONE. 2018;13(11):e0207581. 10.1371/journal.pone.0207581 . Published 2018 Nov 27. Stark P. Das fibröse Pleuramesotheliom (Pleurafibrom). Ein Beitrag zur Differentialdiagnose von Pleuratumoren [Fibrous pleural mesothelioma (pleura fibroma) -- a contribution to the differential diagnosis of pleural tumours (author's transl)]. Rofo. 1981;134(6):614–9. 10.1055/s-2008-1056426 . Zhou C, Li W, Shao J, Zhao J. Thoracic solitary fibrous tumors: an analysis of 70 patients who underwent surgical resection in a single institution. J Cancer Res Clin Oncol. 2020;146(5):1245–52. 10.1007/s00432-020-03151-8 . Magdeleinat P, Alifano M, Petino A, et al. Solitary fibrous tumors of the pleura: clinical characteristics, surgical treatment and outcome. Eur J Cardiothorac Surg. 2002;21(6):1087–93. 10.1016/s1010-7940(02)00099-4 . Koelsche C, Schweizer L, Renner M, et al. Nuclear relocation of STAT6 reliably predicts NAB2-STAT6 fusion for the diagnosis of solitary fibrous tumour. Histopathology. 2014;65(5):613–22. 10.1111/his.12431 . Ajouz H, Sohail AH, Hashmi H, et al. Surgical considerations in the resection of solitary fibrous tumors of the pleura. J Cardiothorac Surg. 2023;18(1):79. 10.1186/s13019-023-02168-7 . Published 2023 Feb 24. Harrison-Phipps KM, Nichols FC, Schleck CD, et al. Solitary fibrous tumors of the pleura: results of surgical treatment and long-term prognosis. J Thorac Cardiovasc Surg. 2009;138(1):19–25. 10.1016/j.jtcvs.2009.01.026 . Milano MT, Singh DP, Zhang H. Thoracic malignant solitary fibrous tumors: A population-based study of survival. J Thorac Dis. 2011;3(2):99–104. 10.3978/j.issn.2072-1439.2011.01.04 . Additional Declarations No competing interests reported. Cite Share Download PDF Status: Under Review Version 1 posted Editorial decision: Revision requested 05 Apr, 2026 Reviews received at journal 10 Feb, 2026 Reviews received at journal 01 Feb, 2026 Reviews received at journal 01 Feb, 2026 Reviewers agreed at journal 29 Jan, 2026 Reviewers agreed at journal 28 Jan, 2026 Reviewers agreed at journal 25 Jan, 2026 Reviews received at journal 24 Jan, 2026 Reviewers agreed at journal 23 Jan, 2026 Reviewers agreed at journal 22 Jan, 2026 Reviewers agreed at journal 21 Jan, 2026 Reviewers invited by journal 21 Jan, 2026 Editor assigned by journal 04 Nov, 2025 Submission checks completed at journal 04 Nov, 2025 First submitted to journal 31 Oct, 2025 You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-8000935","acceptedTermsAndConditions":true,"allowDirectSubmit":false,"archivedVersions":[],"articleType":"Case Report","associatedPublications":[],"authors":[{"id":578525404,"identity":"bcc2edf6-9456-4f5f-943b-f8d2c5145a93","order_by":0,"name":"Amelia Fernández-Avendaño","email":"","orcid":"","institution":"Instituto Nacional de Enfermedades Respiratorias","correspondingAuthor":false,"prefix":"","firstName":"Amelia","middleName":"","lastName":"Fernández-Avendaño","suffix":""},{"id":578525405,"identity":"2082c7e0-b083-4d7b-b469-a5aa0a17eb98","order_by":1,"name":"Mónica Martínez-Ferman","email":"","orcid":"","institution":"Instituto Nacional de Enfermedades Respiratorias","correspondingAuthor":false,"prefix":"","firstName":"Mónica","middleName":"","lastName":"Martínez-Ferman","suffix":""},{"id":578525406,"identity":"fe28b418-8c46-4239-a3a3-d607d5b2fcd3","order_by":2,"name":"Pablo Gomes-da Silva de Rosenzweig","email":"","orcid":"","institution":"Instituto Nacional de Enfermedades Respiratorias","correspondingAuthor":false,"prefix":"","firstName":"Pablo","middleName":"Gomes-da Silva","lastName":"de Rosenzweig","suffix":""},{"id":578525407,"identity":"bc569dc0-0f2f-48d6-b801-d809dcad8202","order_by":3,"name":"Daniel Arizpe-Vilana","email":"","orcid":"","institution":"Instituto Nacional de Enfermedades Respiratorias","correspondingAuthor":false,"prefix":"","firstName":"Daniel","middleName":"","lastName":"Arizpe-Vilana","suffix":""},{"id":578525408,"identity":"4cfa9298-bcc6-4201-a44c-aef26bbc1539","order_by":4,"name":"Luis Fernando Arana-Bolaños","email":"","orcid":"","institution":"Instituto Nacional de Enfermedades Respiratorias","correspondingAuthor":false,"prefix":"","firstName":"Luis","middleName":"Fernando","lastName":"Arana-Bolaños","suffix":""},{"id":578525409,"identity":"59c9a34b-32a4-48a1-851c-b98cb05954e1","order_by":5,"name":"Xcaret Luna-Vargas","email":"","orcid":"","institution":"Instituto Nacional de Enfermedades Respiratorias","correspondingAuthor":false,"prefix":"","firstName":"Xcaret","middleName":"","lastName":"Luna-Vargas","suffix":""},{"id":578525410,"identity":"243af052-0cb6-426e-9a83-a49d6af6ec1d","order_by":6,"name":"León Green Schneeweiss","email":"","orcid":"","institution":"Centro Médico ABC","correspondingAuthor":false,"prefix":"","firstName":"León","middleName":"Green","lastName":"Schneeweiss","suffix":""},{"id":578525411,"identity":"147656e8-9d7b-48ff-9277-75562b651925","order_by":7,"name":"Francina Valezka Bolaños-Morales","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAA8ElEQVRIie3PsYrCMBjA8ZRAXD5axwQ9bnMOCE6ir2IJOHVzOm6wUqiTuPokmRsK7ZIHKLgYfQE7CHW71u2WtrcdmP8Q8sH3gwQhm+1fhkOEEgTe501d6hHcbuK8yJiFa8EbQvqSOU+CCW3mTsJztTOVXgBPNPl6BIsxQdhcizai/YjTQgBTh+z8IUX9MDKdBi2EhX5M+R2Dm7rrM5O4JkBGreRo9tXqvgWUwWzD5LabeNSPUVKkMNQwc0qZ9iEmYqHOgZ2IGDkyB4I7/kI8ocoq+156FKvyKevLIDK3NvIrDK+z73qTU/1l22az2d6mH5wlSRUbvGvsAAAAAElFTkSuQmCC","orcid":"","institution":"Instituto Nacional de Enfermedades Respiratorias","correspondingAuthor":true,"prefix":"","firstName":"Francina","middleName":"Valezka","lastName":"Bolaños-Morales","suffix":""}],"badges":[],"createdAt":"2025-10-31 18:23:20","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-8000935/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-8000935/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":101204060,"identity":"579e9fc3-84cd-4d74-941b-5ecf09d985dc","added_by":"auto","created_at":"2026-01-27 09:41:28","extension":"jpg","order_by":0,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":329114,"visible":true,"origin":"","legend":"","description":"","filename":"Figure1.jpg","url":"https://assets-eu.researchsquare.com/files/rs-8000935/v1/5035ccbdfcf7cb23aa9b9ace.jpg"},{"id":101018757,"identity":"fbf9efc0-cfec-4872-bf8c-fbcf5988dc8f","added_by":"auto","created_at":"2026-01-24 00:34:13","extension":"jpg","order_by":1,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":713949,"visible":true,"origin":"","legend":"","description":"","filename":"Figure2.jpg","url":"https://assets-eu.researchsquare.com/files/rs-8000935/v1/4385b6a71ad4d7ff5e7fb2a0.jpg"},{"id":101018761,"identity":"43d9501b-e022-4116-ae03-039589ad9172","added_by":"auto","created_at":"2026-01-24 00:34:13","extension":"docx","order_by":2,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":18077,"visible":true,"origin":"","legend":"","description":"","filename":"SurgicalapproachtoSFT.docx","url":"https://assets-eu.researchsquare.com/files/rs-8000935/v1/9d6c5a80d6bc29cd8a0d4ea4.docx"},{"id":101204937,"identity":"53560fe1-352b-4c2a-a389-2efaf66fc748","added_by":"auto","created_at":"2026-01-27 09:45:06","extension":"jpg","order_by":3,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":619735,"visible":true,"origin":"","legend":"","description":"","filename":"Figure3.jpg","url":"https://assets-eu.researchsquare.com/files/rs-8000935/v1/838d1ae3497e862a9af37e4f.jpg"},{"id":101018760,"identity":"c46ec978-97c7-4d4d-8912-fb07b404931d","added_by":"auto","created_at":"2026-01-24 00:34:13","extension":"jpg","order_by":4,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":160381,"visible":true,"origin":"","legend":"","description":"","filename":"Figure4.jpg","url":"https://assets-eu.researchsquare.com/files/rs-8000935/v1/4c2311df302e4b789d6ac599.jpg"},{"id":101204008,"identity":"112e7a8c-6e1f-4ac0-a762-d670655b810a","added_by":"auto","created_at":"2026-01-27 09:41:16","extension":"json","order_by":5,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":8020,"visible":true,"origin":"","legend":"","description":"","filename":"72af0795a084409ebe5da8f1db2215c0.json","url":"https://assets-eu.researchsquare.com/files/rs-8000935/v1/72dbb66cee1d62510d728ee4.json"},{"id":101018768,"identity":"7259d941-057a-411e-a39e-c0a34cefe05a","added_by":"auto","created_at":"2026-01-24 00:34:13","extension":"xml","order_by":6,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":54768,"visible":true,"origin":"","legend":"","description":"","filename":"72af0795a084409ebe5da8f1db2215c01enriched.xml","url":"https://assets-eu.researchsquare.com/files/rs-8000935/v1/7cfc6d50d36511526261af58.xml"},{"id":101018767,"identity":"c8a7d9db-2057-4040-90fb-4d1b68f7b9a8","added_by":"auto","created_at":"2026-01-24 00:34:13","extension":"jpg","order_by":7,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":329114,"visible":true,"origin":"","legend":"","description":"","filename":"Figure1.jpg","url":"https://assets-eu.researchsquare.com/files/rs-8000935/v1/a417d67079f81a49c5a9dbd7.jpg"},{"id":101018773,"identity":"03637e73-b0b4-4687-81db-e70f841a589c","added_by":"auto","created_at":"2026-01-24 00:34:13","extension":"jpg","order_by":8,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":713949,"visible":true,"origin":"","legend":"","description":"","filename":"Figure2.jpg","url":"https://assets-eu.researchsquare.com/files/rs-8000935/v1/9b38a1ac20eb14e0230d0136.jpg"},{"id":101018770,"identity":"aaccda69-600b-480f-9120-1c42c9029bb7","added_by":"auto","created_at":"2026-01-24 00:34:13","extension":"jpg","order_by":9,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":619735,"visible":true,"origin":"","legend":"","description":"","filename":"Figure3.jpg","url":"https://assets-eu.researchsquare.com/files/rs-8000935/v1/7b75c7f91163e490d433336f.jpg"},{"id":101018774,"identity":"19601958-75f2-4e3d-971f-0ba7748bd68b","added_by":"auto","created_at":"2026-01-24 00:34:14","extension":"jpg","order_by":10,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":160381,"visible":true,"origin":"","legend":"","description":"","filename":"Figure4.jpg","url":"https://assets-eu.researchsquare.com/files/rs-8000935/v1/090533951084452cfbea2c5a.jpg"},{"id":101018769,"identity":"1f3c4231-6ab7-4b8f-876f-2123a55d7490","added_by":"auto","created_at":"2026-01-24 00:34:13","extension":"png","order_by":11,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":586179,"visible":true,"origin":"","legend":"","description":"","filename":"OnlineFigure1.png","url":"https://assets-eu.researchsquare.com/files/rs-8000935/v1/d26933b5b39af3f4b906750e.png"},{"id":101018775,"identity":"b04aba2d-90c7-4ecf-afb6-ea871fdc01e7","added_by":"auto","created_at":"2026-01-24 00:34:14","extension":"png","order_by":12,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":1820793,"visible":true,"origin":"","legend":"","description":"","filename":"OnlineFigure2.png","url":"https://assets-eu.researchsquare.com/files/rs-8000935/v1/4b54691d3fbe1e1a6a649c0e.png"},{"id":101018766,"identity":"b0e8c7b3-263c-4227-999e-2c3693a2f3e1","added_by":"auto","created_at":"2026-01-24 00:34:13","extension":"png","order_by":13,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":870237,"visible":true,"origin":"","legend":"","description":"","filename":"OnlineFigure3.png","url":"https://assets-eu.researchsquare.com/files/rs-8000935/v1/388dc185ef3823a2d9cada78.png"},{"id":101018776,"identity":"ee218a38-8d05-422b-b872-a7a6a00b85da","added_by":"auto","created_at":"2026-01-24 00:34:14","extension":"png","order_by":14,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":275080,"visible":true,"origin":"","legend":"","description":"","filename":"OnlineFigure4.png","url":"https://assets-eu.researchsquare.com/files/rs-8000935/v1/00beca7f666c2e9855d111e4.png"},{"id":101018772,"identity":"e0603cc1-053e-4a31-9788-cd6a2510eba7","added_by":"auto","created_at":"2026-01-24 00:34:13","extension":"xml","order_by":15,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":53400,"visible":true,"origin":"","legend":"","description":"","filename":"72af0795a084409ebe5da8f1db2215c01structuring.xml","url":"https://assets-eu.researchsquare.com/files/rs-8000935/v1/984ccfb267d314a9b6741801.xml"},{"id":101018771,"identity":"93420242-56da-415d-9c92-40a8e49e8c08","added_by":"auto","created_at":"2026-01-24 00:34:13","extension":"html","order_by":16,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":62652,"visible":true,"origin":"","legend":"","description":"","filename":"earlyproof.html","url":"https://assets-eu.researchsquare.com/files/rs-8000935/v1/b8e2b2270580f39e1a3455bd.html"},{"id":101018756,"identity":"3a3cd4a9-7473-4e34-93b1-86ccb37b44d0","added_by":"auto","created_at":"2026-01-24 00:34:13","extension":"jpg","order_by":1,"title":"Figure 1","display":"","copyAsset":false,"role":"figure","size":329114,"visible":true,"origin":"","legend":"\u003cp\u003eClinical case 1, a)Initial anteroposterior chest X-ray showing a radiopaque mass occupying the left hemithorax (yellow arrows) with rightward tracheal deviation due to compression, b) MRI showing the mediastinal tumour 15x15x10 cm (yellow arrow), c) Thoracotomy with Finochietto retractor, directly visualising the solitary fibrous tumour in the anterior mediastinum, d) Solitary fibrous tumour extracted. 15.5 x 13.5 x 5.5 cm, 934 gr.\u003c/p\u003e","description":"","filename":"Figure1.jpg","url":"https://assets-eu.researchsquare.com/files/rs-8000935/v1/a0719db32d6b64aecc955699.jpg"},{"id":101018758,"identity":"ff8701cd-c33f-41b7-be1a-8d68e352547a","added_by":"auto","created_at":"2026-01-24 00:34:13","extension":"jpg","order_by":2,"title":"Figure 2","display":"","copyAsset":false,"role":"figure","size":713949,"visible":true,"origin":"","legend":"\u003cp\u003eHistological images of clinical case 1, a) Proliferation of spindle-shaped cells is observed, with eosinophilic cytoplasm, spindle-shaped nuclei, granular chromatin, occasional nucleoli, arranged in a fascicular pattern and hemangiopericytoma-like pattern. In these areas, multiple atypical mitotic figures are observed, with increased cellularity and pronounced nuclear pleomorphism. b) In other fields, the neoplasm is interspersed with areas of necrosis. Immunohistochemically, the neoplastic cells are intensely and diffusely positive for BCL-2 (c), CD34 (d), and STAT6 (e). The cell proliferation index, measured with Ki67, is 20% (f). The morphological features and immunostaining characteristics are consistent with a grade 2 solitary fibrous tumour.\u003c/p\u003e","description":"","filename":"Figure2.jpg","url":"https://assets-eu.researchsquare.com/files/rs-8000935/v1/ab084725ab962c645f0b9d60.jpg"},{"id":101018763,"identity":"2f2a5d0d-917c-46a8-98da-57c8a0246113","added_by":"auto","created_at":"2026-01-24 00:34:13","extension":"jpg","order_by":3,"title":"Figure 3","display":"","copyAsset":false,"role":"figure","size":619735,"visible":true,"origin":"","legend":"\u003cp\u003eClinical case 2, a) Chest CT in the non-contrast phase showing a tumour of 5.3 x 5.9 x 9.3 cm (yellow arrow), in the left hemithorax with lobulated characteristics, well-defined contours, homogeneous, in contact with the chest wall and pericardium, displacing the adjacent lung parenchyma, b) Solitary fibrous tumour extracted. 9 x 6 x 5 cm.\u003c/p\u003e","description":"","filename":"Figure3.jpg","url":"https://assets-eu.researchsquare.com/files/rs-8000935/v1/62aac118bceb8b8bb0bc3541.jpg"},{"id":101018762,"identity":"6673cdb6-888d-4db8-a700-d2c594900920","added_by":"auto","created_at":"2026-01-24 00:34:13","extension":"jpg","order_by":4,"title":"Figure 4","display":"","copyAsset":false,"role":"figure","size":160381,"visible":true,"origin":"","legend":"\u003cp\u003eAxial CT. Clinical case 3, anterior mediastinal tumour with well-defined contours, lobulated margins, and homogeneous consistency, measuring 4.2x3.4 cm (yellow arrow)\u003c/p\u003e","description":"","filename":"Figure4.jpg","url":"https://assets-eu.researchsquare.com/files/rs-8000935/v1/fb39008f10ad605466c3a595.jpg"},{"id":101207898,"identity":"68a89085-64d8-42c0-b5d1-808f19032b3b","added_by":"auto","created_at":"2026-01-27 10:07:44","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":2261917,"visible":true,"origin":"","legend":"","description":"","filename":"manuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-8000935/v1/2adf69e4-93e8-46b7-a081-98b9ea6bba50.pdf"}],"financialInterests":"No competing interests reported.","formattedTitle":"Surgical approach to pleuropulmonary solitary fibrous tumour in the anterior mediastinum: Case series at a third-level centre","fulltext":[{"header":"Introduction","content":"\u003cp\u003eSolitary fibrous tumour (SFT) accounts for approximately 3.7\u0026ndash;5% of soft tissue sarcomas and mesenchymal neoplasms. Between 12% and 32% of cases exhibit malignant behaviour, typically affecting individuals between 50 and 70 years of age. Its pathogenesis is associated with a chromosomal inversion at 12q13, resulting in the fusion of the NAB2 and STAT6 genes (\u003cspan citationid=\"CR1\" class=\"CitationRef\"\u003e1\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR2\" class=\"CitationRef\"\u003e2\u003c/span\u003e). These tumours typically arise from serous membranes, with approximately 30% occurring within the thoracic cavity (\u003cspan citationid=\"CR3\" class=\"CitationRef\"\u003e3\u003c/span\u003e). Of thoracic cases, most originate from the visceral pleura and are often attached to the lung by a pedicle. The clinical presentation is variable and often nonspecific, presenting with symptoms such as cough, dyspnea, and chest pain (\u003cspan citationid=\"CR4\" class=\"CitationRef\"\u003e4\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR5\" class=\"CitationRef\"\u003e5\u003c/span\u003e).\u003c/p\u003e \u003cp\u003eThe standard treatment for SFT is complete surgical resection with negative margins. Historically, this has been achieved through thoracotomy; however, given the advantages of minimally invasive approaches, such as reduced intraoperative blood loss and shorter length of hospital stay, both video-assisted thoracic surgery (VATS) and robotic-assisted thoracic surgery (RATS) have emerged as feasible alternatives for tumour resection (\u003cspan additionalcitationids=\"CR7\" citationid=\"CR6\" class=\"CitationRef\"\u003e6\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR8\" class=\"CitationRef\"\u003e8\u003c/span\u003e). The objective of this case series is to present our experience in managing SFT using both conventional open surgery and a minimally invasive robotic-assisted approach.\u003c/p\u003e"},{"header":"Case series","content":"\u003cdiv id=\"Sec3\" class=\"Section2\"\u003e \u003ch2\u003eCase 1 (Fig.\u0026nbsp;\u003cspan refid=\"Fig1\" class=\"InternalRef\"\u003e1\u003c/span\u003e)\u003c/h2\u003e \u003cp\u003e \u003c/p\u003e \u003cp\u003eA 67-year-old female presented with a one-month history of progressive dyspnea, which advanced to orthopnea, rendering her unable to tolerate the supine position. A chest X-ray revealed a mass in the anterior mediastinum. A computed tomography (CT) guided biopsy confirmed the diagnosis of a SFT, and subsequent magnetic resonance imaging (MRI) demonstrated a mass measuring 15 \u0026times; 15 \u0026times; 10 cm. Given the tumour\u0026rsquo;s size, a median sternotomy was performed. The mass was carefully dissected using harmonic energy, preserving the thymic margins. En bloc resection was achieved, including the pedicle arising from the right pulmonary apex. A 32 French pleural drain was placed. Intraoperative bleeding (IOB) was 200 mL, and the operative time was 1.5 hours.\u003c/p\u003e \u003cp\u003eIn the immediate postoperative period, the patient experienced hemodynamic instability requiring vasopressor support and transfusion of blood products. She was managed in the intensive care unit (ICU) with advanced airway support for two days, followed by an uneventful recovery. The pleural drain was removed at 48 hours, and the patient was discharged on postoperative day four. Histopathological analysis confirmed a malignant grade 2 SFT. Immunohistochemistry was positive for CD34, STAT6, and BCL2 (Fig.\u0026nbsp;\u003cspan refid=\"Fig2\" class=\"InternalRef\"\u003e2\u003c/span\u003e).\u003c/p\u003e \u003cp\u003e \u003c/p\u003e \u003c/div\u003e\n\u003ch3\u003eCase 2. (Fig. 3)\u003c/h3\u003e\n\u003cp\u003e \u003c/p\u003e \u003cp\u003e \u003c/p\u003e \u003cp\u003eA 54-year-old female with no significant medical history was admitted to the emergency department with a diagnosis of influenza-related pneumonia. A CT scan incidentally revealed a mass in the left anterior mediastinum. An ultrasound-guided biopsy confirmed the diagnosis of a SFT. The patient was scheduled for resection via RATS, utilising four robotic arms. Under general anaesthesia, she was positioned in the right lateral decubitus position. A single 8 mm port was placed in the 7th intercostal space (ICS) for CO₂ insufflation. Under direct visualisation, additional ports were placed at the 7th and 8th ICS along the posterior axillary line, and a 12 mm accessory port was inserted in the 9th ICS along the anterior axillary line.\u003c/p\u003e \u003cp\u003eThe tumour was identified with firm adhesions to the visceral pleura of the left upper lobe. A wedge resection of the anterior segment was performed using a 60 mm stapler. A 24Fr drain was placed posteriorly, with adequate lung expansion confirmed. IOB was 150 mL, and the procedure lasted 1.5 hours. The patient was successfully extubated in the operating room and experienced an uneventful recovery. The pleural drain was removed on postoperative day two, and she was discharged the same day. Histopathological examination confirmed a benign SFT measuring 9 \u0026times; 6 \u0026times; 5 cm and weighing 156 grams, with an R0 resection. The tumour exhibited a fibrous stroma and positive immunohistochemical staining for CD34, Bcl-2, and CD99.\u003c/p\u003e \u003cp\u003e \u003cstrong\u003eCase 3\u003c/strong\u003e \u003cp\u003e \u003cem\u003e(\u003c/em\u003eFig.\u0026nbsp;\u003cspan refid=\"Fig3\" class=\"InternalRef\"\u003e3\u003c/span\u003e\u003cem\u003e).\u003c/em\u003e\u003c/p\u003e \u003c/p\u003e \u003cp\u003eA 71-year-old female with a history of breast cancer and prior mediastinal tumour resection, with histopathology confirming a SFT, presented after a follow-up CT scan revealed a new mediastinal mass, suggestive of SFT recurrence. The patient was scheduled for RATS resection through 4 ports. Three 8 mm robotic ports and one 12 mm accessory port were utilised. Intraoperatively, multiple loose adhesions were encountered. The tumour was located over the ascending aorta, with displacement of the left brachiocephalic venous trunk. Tumour resection was performed using bipolar energy, achieving complete excision. A 24 Fr drain was placed with full lung re-expansion. IOB was 50 mL, and the operative time was 3 hours.\u003c/p\u003e \u003cp\u003eThe patient was successfully extubated in the operating room and had a favourable postoperative course. The pleural drain was removed on postoperative day four, and she was discharged the same day. Histopathological analysis confirmed a malignant SFT measuring 6.3 \u0026times; 4.4 \u0026times; 3.5 cm and weighing 46 grams. R0 resection was achieved. The tumour exhibited positive staining for CD34 and BCL2.\u003c/p\u003e"},{"header":"Discussion","content":"\u003cp\u003ePleuropulmonary SFTs are rare, with an estimated incidence of 2.8 cases per 100,000 people annually. In Mexico, 26 cases were reported between 2007 and 2017, with a mean age of 52 years and a higher prevalence in females, as described by R\u0026iacute;os-Pascual et al. (\u003cspan citationid=\"CR9\" class=\"CitationRef\"\u003e9\u003c/span\u003e). The diagnosis is most often incidental, with symptoms typically appearing once the tumour reaches sufficient size to compress adjacent structures. In our series, as well as in the literature, CT scanning is the preferred diagnostic modality for benign tumours, which usually demonstrate a hyperdense, encapsulated mass with a pedunculated growth often attached to the left basal region, arising from the visceral pleura. In contrast, malignant tumours tend to show more invasive growth with organ infiltration, hemorrhagic necrosis, and a higher risk of recurrence (\u003cspan citationid=\"CR10\" class=\"CitationRef\"\u003e10\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR11\" class=\"CitationRef\"\u003e11\u003c/span\u003e). For diagnostic confirmation, biopsy may be performed, with immunohistochemical positivity for markers such as CD34, CD99, and Bcl-2 (\u003cspan citationid=\"CR9\" class=\"CitationRef\"\u003e9\u003c/span\u003e). Although most SFTs are benign (\u003cspan citationid=\"CR12\" class=\"CitationRef\"\u003e12\u003c/span\u003e), when malignant, they may be negative for CD34, which can be explained by tumour dedifferentiation, leading to changes in the expression of surface proteins.\u003c/p\u003e \u003cp\u003eAs exemplified by our cases, the location of the intrathoracic SFT should guide consideration of the differential diagnosis. For anterior mediastinal tumours, a practical mnemonic is the \u0026ldquo;4Ts\u0026rdquo;: thymoma, teratoma, thyroid pathology, and \u0026ldquo;terrible\u0026rdquo; lymphoma (\u003cspan citationid=\"CR13\" class=\"CitationRef\"\u003e13\u003c/span\u003e). Attention to paraneoplastic manifestations may also aid diagnostic certainty. Doege-Potter syndrome, characterised by hypoglycemia due to ectopic insulin-like growth factor production, is described in up to 22% of SFT cases. Pierre-Marie-Bamberg syndrome, although rarer and reported in fewer than 5% of cases, is another recognised paraneoplastic presentation with digital clubbing and hypertrophic osteoarthropathy (\u003cspan citationid=\"CR12\" class=\"CitationRef\"\u003e12\u003c/span\u003e).\u003c/p\u003e \u003cp\u003eThe treatment for SFT is surgical resection, which, depending on the extent of the tumour, may require the removal of adherent or invaded tissues. However, Wang et al. reported no significant differences in disease-free survival at five years when comparing organ-sparing versus en bloc resections. This finding, though, should be interpreted with caution, as it may be influenced by the small sample size of the study (\u003cspan citationid=\"CR14\" class=\"CitationRef\"\u003e14\u003c/span\u003e).\u003c/p\u003e \u003cp\u003eConventionally, resection has been carried out through open surgery, particularly when larger than 5 cm. However, the recent development of minimally invasive thoracic surgery has offered an alternative for the treatment of SFT (\u003cspan citationid=\"CR15\" class=\"CitationRef\"\u003e15\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR16\" class=\"CitationRef\"\u003e16\u003c/span\u003e). Video-assisted thoracoscopic surgery (VATS) has demonstrated favourable outcomes, as shown in studies by Magdeleinat et al. and Zhou et al. (\u003cspan citationid=\"CR16\" class=\"CitationRef\"\u003e16\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR17\" class=\"CitationRef\"\u003e17\u003c/span\u003e). Similarly, RATS has emerged as a safe and effective option for SFT resection, as exemplified by our series of patients. Nevertheless, it\u0026acute;s important to note that most published reports remain limited to case series, and no studies have directly compared outcomes between RATS and VATS or RATS and open surgery, despite the early, promising results of robotic resections. While minimally invasive resections offer benefits such as reduced postoperative pain and faster recovery, careful incision planning is essential to ensure an adequate working space and to allow safe tumour extraction while minimising the risk of tumour seeding (\u003cspan citationid=\"CR18\" class=\"CitationRef\"\u003e18\u003c/span\u003e). Moreover, conversion to open thoracotomy should always be considered when complete resection with clear margins cannot be achieved (\u003cspan citationid=\"CR19\" class=\"CitationRef\"\u003e19\u003c/span\u003e).\u003c/p\u003e \u003cp\u003eIn general, SFTs have a good prognosis, with reported overall survival rates of 89\u0026ndash;100% at 5 years (\u003cspan citationid=\"CR16\" class=\"CitationRef\"\u003e16\u003c/span\u003e, \u003cspan citationid=\"CR20\" class=\"CitationRef\"\u003e20\u003c/span\u003e). However, this favourable outcome largely applies to benign SFTs. Malignant tumours carry a higher risk of recurrence, with a reported 5-year disease-free status of around 58% and an overall survival of approximately 67% (\u003cspan citationid=\"CR21\" class=\"CitationRef\"\u003e21\u003c/span\u003e). Although our series is not representative of the typical distribution of benign and malignant SFTs (with a predominance of malignant cases), the cornerstone of treatment remains complete surgical resection. Adjuvant radiotherapy and/or chemotherapy may help reduce recurrence rates in this set of patients; however, their benefit has only been demonstrated in a small number of studies, and overall efficacy remains uncertain (\u003cspan citationid=\"CR5\" class=\"CitationRef\"\u003e5\u003c/span\u003e, \u003cspan citationid=\"CR21\" class=\"CitationRef\"\u003e21\u003c/span\u003e).\u003c/p\u003e \u003cp\u003eThe limitations of our study include its retrospective nature and the small number of patients in our series. However, a clear need remains for prospective, comparative studies evaluating the outcomes of minimally invasive resections for SFT compared to conventional open approaches.\u003c/p\u003e"},{"header":"Conclusion","content":"\u003cp\u003eThe diagnosis of SFT is often incidental, and complete surgical resection is the treatment of choice. Minimally invasive surgery, such as RATS resection, appears to be effective for tumours smaller than 10 cm, with a good postoperative recovery and reduced frequency of complications. Despite its good prognosis, postoperative surveillance is crucial due to the possibility of recurrence in the first two years. A multidisciplinary approach is essential to ensure proper management and optimise outcomes.\u003c/p\u003e"},{"header":"Abbreviations","content":"\u003cp\u003esolitary fibrous tumour (SFT)\u003c/p\u003e\n\u003cp\u003evideo-assisted thoracic surgery (VATS)\u003c/p\u003e\n\u003cp\u003erobotic-assisted thoracic surgery (RATS)\u003c/p\u003e\n\u003cp\u003ecomputed tomography (CT)\u003c/p\u003e\n\u003cp\u003emagnetic resonance imaging (MRI)\u003c/p\u003e\n\u003cp\u003eintensive care unit (ICU)\u003c/p\u003e\n\u003cp\u003eintercostal space (ICS)\u003c/p\u003e\n\u003cp\u003eintraoperative bleeding (IOB)\u003c/p\u003e"},{"header":"Declarations","content":"\u003cp\u003e\u003cstrong\u003eData availability\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eNot applicable.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAcknowledgements\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eNone\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eFunding\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eNone provided\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eEthics approval\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003ePatients provided informed consent for publication.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eCompeting interests\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eNone declared\u0026nbsp;\u003c/p\u003e\u003ch2\u003eAuthor Contribution\u003c/h2\u003e\u003cp\u003e[AMF, MMF, PGD, DAV, LFA, XLV, LGS ,FVB] performed the literature review and contributed to manuscript drafting. [ LGS ,FVB] supervised the project and critically revised the final version. All authors reviewed and approved the manuscript.\u003c/p\u003e"},{"header":"References","content":"\u003col\u003e\u003cli\u003e\u003cspan\u003eFranzen D, Diebold M, Soltermann A et al. Determinants of outcome of solitary fibrous tumors of the pleura: an observational cohort study. BMC Pulm Med. 2014;14:138. Published 2014 Aug 12. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1186/1471-2466-14-138\u003c/span\u003e\u003cspan address=\"10.1186/1471-2466-14-138\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eSchweizer L, Koelsche C, Sahm F, et al. Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein. Acta Neuropathol. 2013;125(5):651\u0026ndash;8. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1007/s00401-013-1117-6\u003c/span\u003e\u003cspan address=\"10.1007/s00401-013-1117-6\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eMartin-Broto J, Mondaza-Hernandez JL, Moura DS, Hindi N. A Comprehensive Review on Solitary Fibrous Tumor: New Insights for New Horizons. Cancers (Basel). 2021;13(12):2913. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.3390/cancers13122913\u003c/span\u003e\u003cspan address=\"10.3390/cancers13122913\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e. Published 2021 Jun 10.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eKhouzam MS, Khouzam N. Malignant solitary fibrous tumor of the pleura. J Cardiothorac Surg. 2022;17(1):92. Published 2022 May 3. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1186/s13019-022-01842-6\u003c/span\u003e\u003cspan address=\"10.1186/s13019-022-01842-6\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eGao X, Zhang J, Qian Z, Liu L. Malignant solitary fibrous tumor of the pleura: A narrative review of clinical characteristics, diagnosis and therapeutic options. Respir Med Res. 2022;86:100961. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1016/j.resmer.2022.100961\u003c/span\u003e\u003cspan address=\"10.1016/j.resmer.2022.100961\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eGonzalez-Rivas D, Gomes-da Silva de Rosenzweig P, Arana Bola\u0026ntilde;os LF, et al. Complex uniportal robotic-assisted sleeve resections under spontaneous ventilation and with double lumen intubation: a case series and a narrative review of the literature. Transl Lung Cancer Res. 2025;14(8):3170\u0026ndash;82. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.21037/tlcr-2025-498\u003c/span\u003e\u003cspan address=\"10.21037/tlcr-2025-498\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003evan Reesema LLS, Hutchcraft ML, Freidberg NA, et al. Robot-assisted laparoscopic removal of an extraperitoneal pelvic solitary fibrous tumor. Gynecol Oncol Rep. 2023;47:101198. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1016/j.gore.2023.101198\u003c/span\u003e\u003cspan address=\"10.1016/j.gore.2023.101198\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e. Published 2023 May 16.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eKhouzam MS, Khouzam N. Malignant solitary fibrous tumor of the pleura. J Cardiothorac Surg. 2022;17(1):92. Published 2022 May 3. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1186/s13019-022-01842-6\u003c/span\u003e\u003cspan address=\"10.1186/s13019-022-01842-6\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eR\u0026iacute;os-Pascual S, V\u0026aacute;zquez-Minero JC, Garza-Jim\u0026eacute;nez GO, L\u0026oacute;pez-Luna JJ, Islem-Gamboa T. Tumor fibroso solitario de la pleura: Factores asociados a comportamiento maligno y recidiva. Experiencia institucional. Neumol. cir. torax. 2019 March; 78(1): 25\u0026ndash;31.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eChu X, Zhang L, Xue Z, et al. Solitary fibrous tumor of the pleura: An analysis of forty patients. J Thorac Dis. 2012;4(2):146\u0026ndash;54. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.3978/j.issn.2072-1439.2012.01.05\u003c/span\u003e\u003cspan address=\"10.3978/j.issn.2072-1439.2012.01.05\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eCardinale L. CT Imaging of Solitary fibrous tumour of the pleura (SFTP): Typical Patterns and pitfalls. J Thorac Dis. 2012;4(2):112\u0026ndash;3. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.3978/j.issn.2072-1439.2011.09.01\u003c/span\u003e\u003cspan address=\"10.3978/j.issn.2072-1439.2011.09.01\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eAlghamdi ZM, Othman SA, Al-Yousef MJ, AlFadel BZ. Intrapulmonary location of benign solitary fibrous tumor. Ann Thorac Med. 2020;15(2):98\u0026ndash;101. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.4103/atm.ATM_14_20\u003c/span\u003e\u003cspan address=\"10.4103/atm.ATM_14_20\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eGirard N, Ruffini E, Marx A, Faivre-Finn C, Peters S, ESMO Guidelines Committee. Thymic epithelial tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(Suppl 5):v40\u0026ndash;55. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1093/annonc/mdv277\u003c/span\u003e\u003cspan address=\"10.1093/annonc/mdv277\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eWang Y, Wei R, Ji T, Chen Z, Guo W. Surgical treatment of primary solitary fibrous tumors involving the pelvic ring. PLoS ONE. 2018;13(11):e0207581. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1371/journal.pone.0207581\u003c/span\u003e\u003cspan address=\"10.1371/journal.pone.0207581\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e. Published 2018 Nov 27.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eStark P. Das fibr\u0026ouml;se Pleuramesotheliom (Pleurafibrom). Ein Beitrag zur Differentialdiagnose von Pleuratumoren [Fibrous pleural mesothelioma (pleura fibroma) -- a contribution to the differential diagnosis of pleural tumours (author's transl)]. Rofo. 1981;134(6):614\u0026ndash;9. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1055/s-2008-1056426\u003c/span\u003e\u003cspan address=\"10.1055/s-2008-1056426\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eZhou C, Li W, Shao J, Zhao J. Thoracic solitary fibrous tumors: an analysis of 70 patients who underwent surgical resection in a single institution. J Cancer Res Clin Oncol. 2020;146(5):1245\u0026ndash;52. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1007/s00432-020-03151-8\u003c/span\u003e\u003cspan address=\"10.1007/s00432-020-03151-8\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eMagdeleinat P, Alifano M, Petino A, et al. Solitary fibrous tumors of the pleura: clinical characteristics, surgical treatment and outcome. Eur J Cardiothorac Surg. 2002;21(6):1087\u0026ndash;93. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1016/s1010-7940(02)00099-4\u003c/span\u003e\u003cspan address=\"10.1016/s1010-7940(02)00099-4\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eKoelsche C, Schweizer L, Renner M, et al. Nuclear relocation of STAT6 reliably predicts NAB2-STAT6 fusion for the diagnosis of solitary fibrous tumour. Histopathology. 2014;65(5):613\u0026ndash;22. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1111/his.12431\u003c/span\u003e\u003cspan address=\"10.1111/his.12431\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eAjouz H, Sohail AH, Hashmi H, et al. Surgical considerations in the resection of solitary fibrous tumors of the pleura. J Cardiothorac Surg. 2023;18(1):79. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1186/s13019-023-02168-7\u003c/span\u003e\u003cspan address=\"10.1186/s13019-023-02168-7\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e. Published 2023 Feb 24.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eHarrison-Phipps KM, Nichols FC, Schleck CD, et al. Solitary fibrous tumors of the pleura: results of surgical treatment and long-term prognosis. J Thorac Cardiovasc Surg. 2009;138(1):19\u0026ndash;25. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1016/j.jtcvs.2009.01.026\u003c/span\u003e\u003cspan address=\"10.1016/j.jtcvs.2009.01.026\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eMilano MT, Singh DP, Zhang H. Thoracic malignant solitary fibrous tumors: A population-based study of survival. J Thorac Dis. 2011;3(2):99\u0026ndash;104. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.3978/j.issn.2072-1439.2011.01.04\u003c/span\u003e\u003cspan address=\"10.3978/j.issn.2072-1439.2011.01.04\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003c/ol\u003e"}],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":true,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":false,"highlight":"","institution":"","isAcceptedByJournal":true,"isAuthorSuppliedPdf":false,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":false,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"
[email protected]","identity":"journal-of-cardiothoracic-surgery","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"jcts","sideBox":"Learn more about [Journal of Cardiothoracic Surgery](http://cardiothoracicsurgery.biomedcentral.com)","snPcode":"13019","submissionUrl":"https://submission.nature.com/new-submission/13019/3","title":"Journal of Cardiothoracic Surgery","twitterHandle":"@BioMedCentral","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"em","reportingPortfolio":"BMC/SO AJ","inReviewEnabled":true,"inReviewRevisionsEnabled":true},"keywords":"Pleuropulmonary neoplasia, anterior mediastinum, robot-assisted surgery, solitary fibrous tumour","lastPublishedDoi":"10.21203/rs.3.rs-8000935/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-8000935/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003eSolitary fibrous tumour (SFT) is an uncommon neoplasm, and its occurrence in the anterior mediastinum is particularly rare, as other differential diagnoses would initially be considered. Clinically, SFTs are typically asymptomatic and are often discovered incidentally through imaging studies. Definitive treatment is achieved through complete surgical resection with negative margins, followed by subsequent histopathological analysis. We present three cases of anterior mediastinal SFT managed at our institution in 2024, treated via both open surgery and a minimally invasive approach using robotic-assisted thoracic surgery. Additionally, we discussed the clinical considerations and criteria guiding the choice between open and robotic surgical approaches.\u003c/p\u003e","manuscriptTitle":"Surgical approach to pleuropulmonary solitary fibrous tumour in the anterior mediastinum: Case series at a third-level centre","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2026-01-24 00:34:08","doi":"10.21203/rs.3.rs-8000935/v1","editorialEvents":[{"type":"communityComments","content":0},{"type":"decision","content":"Revision requested","date":"2026-04-05T10:16:50+00:00","index":"","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2026-02-10T10:52:47+00:00","index":"hide","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2026-02-01T17:47:33+00:00","index":"hide","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2026-02-01T17:05:09+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"306194674643028865392139387452021303747","date":"2026-01-29T19:11:11+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"225850540370183764426533691893596427059","date":"2026-01-28T14:47:59+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"340175924166667886804103124119420542981","date":"2026-01-25T19:22:04+00:00","index":"hide","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2026-01-24T15:33:31+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"76327786544669587626467713609425968013","date":"2026-01-23T13:34:49+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"232585895451766244746527208924164236452","date":"2026-01-22T06:17:01+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"326677962229771681887286574940725104376","date":"2026-01-21T12:20:12+00:00","index":"hide","fulltext":""},{"type":"reviewersInvited","content":"","date":"2026-01-21T10:13:15+00:00","index":"","fulltext":""},{"type":"editorAssigned","content":"","date":"2025-11-04T14:24:25+00:00","index":"","fulltext":""},{"type":"checksComplete","content":"","date":"2025-11-04T14:22:33+00:00","index":"","fulltext":""},{"type":"submitted","content":"Journal of Cardiothoracic Surgery","date":"2025-10-31T18:15:46+00:00","index":"","fulltext":""}],"status":"published","journal":{"display":true,"email":"
[email protected]","identity":"journal-of-cardiothoracic-surgery","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"jcts","sideBox":"Learn more about [Journal of Cardiothoracic Surgery](http://cardiothoracicsurgery.biomedcentral.com)","snPcode":"13019","submissionUrl":"https://submission.nature.com/new-submission/13019/3","title":"Journal of Cardiothoracic Surgery","twitterHandle":"@BioMedCentral","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"em","reportingPortfolio":"BMC/SO AJ","inReviewEnabled":true,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"89629ee3-4409-4cd8-a6ad-fa74c1d422c3","owner":[],"postedDate":"January 24th, 2026","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"under-review","subjectAreas":[],"tags":[],"updatedAt":"2026-04-11T10:24:53+00:00","versionOfRecord":[],"versionCreatedAt":"2026-01-24 00:34:08","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-8000935","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-8000935","identity":"rs-8000935","version":["v1"]},"buildId":"XKTyCvWXoU3ODBz1xrDgd","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.